Production of functional peptides with inhibition ability against angiotensin I-Converting enzyme using P. pastoris expression system

J Food Drug Anal. 2018 Jul;26(3):1097-1104. doi: 10.1016/j.jfda.2018.02.001. Epub 2018 Feb 21.

Abstract

To obtain the angiotension-I converting enzyme inhibitor (ACEI), a fusion ACEI polypeptide encoded with 8 DNA sequences of GPL, GPM, IKW, IVY, IRPVQ, IWHHT, IYPRY and IAPG, which were selected and designed and cloned into pGAPZαC and then transformed into Pichia pastoris SMD1168H. After 3 days induction, the fraction with highest ACEI activity was expressed and purified using a Ni Sepharose™ 6 Fast Flow. The IC50 of recombinant ACEI polypeptide was 88.2 μM. A 128-fold increase of ACEI activity (0.69 μM) was obtained after pepsin digestion, which was equivalent to 0.022 μM of captopril. Reverse phase HPLC indicated all the 8 peptides contained in ACEI-hydrolysate after pepsin digestion.

Keywords: Angiotesin I-converting enzyme inhibitory peptides; Cloning; Expression.

MeSH terms

  • Amino Acid Sequence
  • Angiotensin-Converting Enzyme Inhibitors / chemistry
  • Angiotensin-Converting Enzyme Inhibitors / isolation & purification
  • Angiotensin-Converting Enzyme Inhibitors / metabolism*
  • Cloning, Molecular
  • Gene Expression*
  • Genetic Vectors / genetics
  • Genetic Vectors / metabolism
  • Humans
  • Peptides / chemistry
  • Peptides / genetics*
  • Peptides / isolation & purification
  • Peptides / metabolism
  • Peptidyl-Dipeptidase A / chemistry
  • Pichia / genetics*
  • Pichia / metabolism
  • Transformation, Genetic

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Peptides
  • Peptidyl-Dipeptidase A